BAC
stock NYSEKey stats
- Open
- $51.00
- -0.45%
- Close
- $51.49
- +0.51%
- Current
- $51.49
- Prev close
- $51.23
- Today
- 27.46M
- 3-mo avg
- 39.07M
Fundamentals
Each ratio reads FY2025 figures against the latest price, graded so the quality shows at a glance.
At 14x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 2.1% yield is a healthy, generally sustainable level of cash income.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 27.0% margin is strong; the company keeps a healthy slice of every revenue dollar.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 10.1% return on equity is respectable, in the normal range.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 0.9% return on assets is low; the asset base is generating little profit.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 10.25, the company leans heavily on borrowing, which adds risk if results weaken.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
This company does not report a current-assets breakdown, so the ratio cannot be computed.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 6.8% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 13.1% from the prior year: strong profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financials
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $89.1B | $95.0B | $102.8B | $105.9B | $113.1B |
| Net income | $32.0B | $27.5B | $26.3B | $27.0B | $30.5B |
| Diluted EPS | $3.57 | $3.19 | $3.05 | $3.19 | $3.81 |
| Dividend / share | $0.78 | $0.86 | $0.92 | $1.00 | $1.08 |
| Total assets | $3.2T | $3.1T | $3.2T | $3.3T | $3.4T |
| Total liabilities | $2.9T | $2.8T | $2.9T | $3.0T | $3.1T |
| Shareholder equity | $270.1B | $273.2B | $290.2B | $294.0B | $303.2B |
| Q3-2023 | Q1-2024 | Q2-2024 | Q3-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.2B | $25.8B | $25.4B | $25.3B | $28.2B | $26.5B | $28.1B | $30.3B |
| Net income | $7.8B | $6.7B | $6.9B | $6.9B | $7.4B | $7.1B | $8.5B | $8.6B |
| Diluted EPS | $0.90 | $0.76 | $0.83 | $0.81 | $0.89 | $0.89 | $1.06 | $1.11 |
| Dividend / share | · | · | · | $0.24 | $0.26 | $0.26 | $0.26 | $0.28 |
Recent SEC filings
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- DEF 14A Proxy statement
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report